stars 1 stars 2 stars 3

At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit. Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the cure, which is why we are committed to pursuing cell therapy as a transformative treatment option for as many people with cancer as possible who may benefit. Cancer is personal to us. Unlike traditional pharmaceutical manufacturing, our therapies are not created on an assembly line. Cell therapy specialists at our manufacturing facilities reengineer a patient’s own immune cells to attack and fight their cancer cells — one patient at a time. That sense of connection to the people we serve motivates us daily at Kite. Our corporate headquarters are located in Santa Monica, California, and we have dedicated cell therapy manufacturing facilities in California, Maryland and the Netherlands. If you’re passionate about changing the future of cancer treatment, let’s talk. See our community guidelines: http://bit.ly/2DznMNw

View Top Employees from Kite Pharma
Website http://www.kitepharma.com
Ticker NASDAQ:KITE
Revenue $353 million
Funding $225 million
Employees 4,026 (3,972 on RocketReach)
Founded 2009
Address 2400 Broadway, Santa Monica, California 90404, US
Phone (310) 824-9999
Technologies
Industry Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Cancer Treatment, Pharmaceuticals, Science and Engineering, Engineered Autologous Cell Therapy (eACT), Healthcare, Health Care, Immunotherapy, Medical, T-Cells
Web Rank 725798
Web Visits 55330
Keywords Hematologic Malignancies, Innovative Cancer Treatments
Competitors BioNTech SE, Dendreon, Intercept Pharmaceuticals, Pharmacyclics, an AbbVie Company, Seagen
SIC SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies

Kite Pharma Questions

The Kite Pharma annual revenue was $353 million in 2024.

Prentice Curry is the Senior Vice President Quality and Compliance of Kite Pharma.

3,972 people are employed at Kite Pharma.

Kite Pharma is based in Santa Monica, California.

The NAICS codes for Kite Pharma are [3254, 32, 325414, 325, 32541].

The SIC codes for Kite Pharma are [28, 283].

Top Kite Pharma Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users